GSK (LON:GSK) Rating Reiterated by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of GSK (LON:GSK) in a research report report published on Friday, MarketBeat reports. They currently have a GBX 1,950 ($24.66) price objective on the stock.

Several other research analysts have also recently weighed in on GSK. JPMorgan Chase & Co. reiterated an underweight rating on shares of GSK in a research note on Tuesday, June 18th. Citigroup reiterated a buy rating and set a GBX 2,100 ($26.56) price target on shares of GSK in a research note on Monday, June 24th. Shore Capital reiterated a buy rating on shares of GSK in a research note on Thursday, June 27th. Barclays reiterated an equal weight rating and set a GBX 1,725 ($21.82) price target on shares of GSK in a research note on Tuesday, May 7th. Finally, Jefferies Financial Group reiterated a buy rating and set a GBX 2,100 ($26.56) price target on shares of GSK in a research note on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, GSK currently has a consensus rating of Moderate Buy and a consensus target price of GBX 1,791.25 ($22.66).

GSK Trading Down 0.2 %

LON:GSK opened at GBX 1,526 ($19.30) on Friday. The company has a current ratio of 0.87, a quick ratio of 0.73 and a debt-to-equity ratio of 134.34. GSK has a 12 month low of GBX 1,302.60 ($16.48) and a 12 month high of GBX 1,823.50 ($23.06). The company has a market cap of £62.26 billion, a PE ratio of 1,400.00, a price-to-earnings-growth ratio of 1.19 and a beta of 0.27. The company has a 50 day simple moving average of GBX 1,685.84 and a two-hundred day simple moving average of GBX 1,632.29.

GSK Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio (DPR) is 5,504.59%.

Insider Activity at GSK

In related news, insider Wendy Becker purchased 446 shares of GSK stock in a transaction on Thursday, June 20th. The shares were bought at an average cost of GBX 1,614 ($20.41) per share, for a total transaction of £7,198.44 ($9,105.03). 1.60% of the stock is owned by corporate insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.